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Abstract
Sepsis is one of the major causes of human morbidity and results in a considerable number of deaths each year.
Lipopolysaccharide-induced sepsis has been associated with TLR4 signalling pathway which in collaboration with the JAK/
STAT signalling regulate endotoxemia and inflammation. However, during sepsis our immune system cannot maintain a
balance of cytokine levels and results in multiple organ damage and eventual death. Different opinions have been made in
previous studies about the expression patterns and the role of proinflammatory cytokines in sepsis that attracted our
attention towards qualitative properties of TLR4 and JAK/STAT signalling pathways using computer-aided studies. Rene´
Thomas’ formalism was used to model septic and non-septic dynamics of TLR4 and JAK/STAT signalling. Comparisons
among dynamics were made by intervening or removing the specific interactions among entities. Among our predictions,
recurrent induction of proinflammatory cytokines with subsequent downregulation was found as the basic characteristic of
septic model. This characteristic was found in agreement with previous experimental studies, which implicate that
inflammation is followed by immunomodulation in septic patients. Moreover, intervention in downregulation of
proinflammatory cytokines by SOCS-1 was found desirable to boost the immune responses. On the other hand,
interventions either in TLR4 or transcriptional elements such as NFkB and STAT were found effective in the downregulation
of immune responses. Whereas, IFN-b and SOCS-1 mediated downregulation at different levels of signalling were found to
be associated with variations in the levels of proinflammatory cytokines. However, these predictions need to be further
validated using wet laboratory experimental studies to further explore the roles of inhibitors such as SOCS-1 and IFN-b,
which may alter the levels of proinflammatory cytokines at different stages of sepsis.
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Introduction
Sepsis is a serious medical condition associated with complica-
tions of an exacerbated human immune response against
endotoxin/lipopolysaccharides (LPS) mediated severe infections
[1]. It can lead to endotoxin shock, organ damage, morbidity and
eventual death [2,3]. The incidence of sepsis is growing regardless
of advances in the therapeutic and supportive treatments [4,5]. In
1992, nearly 500,000 cases of sepsis were found in the United
States among which 35% of the patients led to mortality [6]. In
2001, around 750,000 cases of sepsis with 28.6% mortality rate per
annum was recorded [7]. In a trend analysis from 1993 to 2003, a
significant increase in the cases of severe sepsis and hospitalization
was reported [8], which is still rising [9].
Pro- and anti-inflammatory cytokines are groups of proteins,
which mediate endogenous inflammation and immunomodula-
tion, respectively. Proinflammatory cytokines (PICyts) including
tumour necrosis factor (TNF)-a, interferon (IFN)-c, interleukin
(IL)-la, IL-1b and IL-6 induce a series of immune responses to
overcome the pathogen load [10]. In contrast, anti-inflammatory
cytokines such as transforming growth factor (TGF)-b, IL-4, IL-10,
IL-13 and other cytokine inhibitors including soluble tumour
necrosis factor receptor (sTNFR)-I and II, IL-lra, or soluble IL-1
receptors (sIL-1r) modulate the immune responses and can induce
temporary immunosuppression in septic patients [11].
Our understandings about the contributory role of pro- and
anti-inflammatory immune responses in sepsis evolved with the
passage of time and highlighted disparities among the scientific
findings. Earlier animal studies suggested that proinflammatory
responses were the major cause of the systemic inflammatory
response syndrome (SIRS) and mortality, whereas anti-inflamma-
tory responses were associated with comparatively less severe
complications [12]. In contrast, recently submitted suggestions
disprove previous studies and indicated that the anti-inflammatory
responses and immunosuppression might in fact be responsible for
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compensatory anti-inflammatory response syndrome (CARS),
severe sepsis, organ damage and subsequent mortality [13–17].
Moreover, other studies implicated that pro- and anti-inflamma-
tory responses are correlated with each other and provide
opportunities for septic patients for the management of pathogens
and hyperinflammation at different levels of sepsis [18,19].
Toll like receptors (TLRs) are pattern recognition receptors and
play their important role in the induction of innate immunity
against endotoxins [20]. Previous studies have demonstrated that
the expression levels of TLR4 were elevated on human monocytes
in healthy volunteers challenged with LPS [21] as well as in septic
patients [22,23]. Activation of TLR4 leads to the production of
pro- and anti-inflammatory cytokines by inducing two different
signalling pathways [24]. TLR4 is unique among other TLRs due
to its ability to induce myeloid differentiation primary response
gene (MyD)88 and TIR-domain-containing-adapter-inducing
interferon-b (TRIF) dependent pathways [25]. These two path-
ways culminate in the generation of PICyts and Interferon-b (IFN-
b), respectively. Along with the production of IFN-b, TRIF
dependent signalling has also been implicated to induce the NFkB
activation through TRAF6 [26]. On the other hand, IFN-b has
been implicated in the modulation of late hyperinflammation in
sepsis [27]. Figure 1 is the simple representation of the TLR4 and
Janus kinase (JAK)/signal transducer and activator of transcription
(STAT) (JAK/STAT) signalling pathways adapted from previous
experimental studies and databases associated with biological
signalling [28–34].
MyD88 dependent pathway activates due to the formation of a
complex between MyD88, TLR4 and toll-interleukin 1 receptor
(TIR) domain containing adaptor protein (TIRAP also known as
MAL). This pathway culminates in the activation of NFkB with
subsequent production of PICyts [35]. In contrast, the TRIF
dependent pathway is activated by the formation of a complex
between TRIF, TRIF related adaptor molecule (TRAM or
TICAM2) and TLR4 [36]. This complex results in the activation
of transcriptional regulator interferon regulatory factor 3 (IRF3)
with subsequent transcription of IFN-b [37]. Moreover, the TRIF
dependent pathway has also been implicated for the delayed
activation of NFkB, through TRIF mediated TRAF6 activation,
however, MyD88 dependent pathway is reported for its explicit
contribution in the production of PICyts [38]. PICyts and IFN-b
mediated JAK/STAT signalling is essential for the induction of
pro- or anti-inflammatory immune responses, respectively [31,39].
PICyts and IFN-b stimulate JAKs with subsequent translocation of
STATs into the nucleus where it transcribes necessary genes
responsible to react appropriately against the pathogen or
inflammation [30,31].
TLR4 mediated immune responses are downregulated by
several negative feedback mechanisms [40]. Regulation of TLR4
mediated signalling maintain homeostasis between infectious
challenge and hyperinflammatory responses [41]. Negative
regulatory proteins such as suppressor of cytokine signalling-1
(SOCS-1), A20 zinc finger protein and sterile alpha-and armadillo-
motif-containing protein (SARM) are well reported for their
inhibitory roles in TLR4 signalling [42–44]. Recently, IFN-b is
found associated with the induction of TH1 to TH2 response shift
to reduce the levels of circulating PICyts [27,45–47]. Various
experiments on SOCS-1 knockout cells highlighted that SOCS-1
is necessary to protect against endotoxemia and hyperinflamma-
tion by inhibiting PICyts and IFN-b mediated JAK/STAT
signalling, respectively [48–50].
In this study, we devised qualitative (discrete) model of TLR4
and JAK/STAT signalling, which was constructed by using the
well-known mathematical formalism of Rene´ Thomas [51–53].
Construction of the models according to this formalism do not
require quantitative data (the expression of entities and kinetic rate
parameters of reactions), which is often difficult to obtain for the
biological regulatory networks (BRNs) [54]. Construction of the
qualitative model requires only the qualitative thresholds and
logical parameters, which can be easily adjusted (see Definitions in
Material and Methods section). The qualitative model encom-
passes all the possible qualitative states or levels of entities present
in a BRN. The dynamics of the BRN are captured by the state
graph (representing the states and trajectories) where important
behaviours can be seen as cyclic paths and paths diverging towards
stable states. These cycles and stable states represent the activation
profiles of the entities, respectively. The advantage of the state
graph is that it can represent a state space in any dimension as a
discrete abstraction, while in other approaches, like ordinary
differential equations, this may be very challenging. Comparison
of the qualitative model with its differential equation counterpart is
given by Rene´ Thomas et al. in [55] to prove that both approaches
are equivalent, however, the qualitative modelling is more suitable
for model checking based reasoning to infer unknown parameters
[56].
In our previous study, TLR4 mediated MyD88 dependent
pathway was studied, with a particular focus on the role of
Bruton’s tyrosine kinase and MAL in the production of
hyperinflammatory responses especially in the case of cerebral
malaria [57]. The current study presents the dynamics of the
TLR4 and JAK/STAT signalling pathway by updating our
previous study with new interactions and entities to gain an insight
into a different pathological condition of sepsis. Additionally, the
current study also provides an understanding about the impor-
tance of signalling downregulated by SOCS-1, IFN-b, A20 and
SARM. Moreover, modelling of interventions in signalling were
used to understand the roles of NFkB, PICyts, IFN-b, JAK/STAT
and SOCS-1 in immune responses [55].
The BRN of TLR4-JAK/STAT (Figure 2) in this study
implicates that TLR4, IFN-b, JAK/STAT and SOCS-1 mediated
signalling perform their roles in a recursive manner. Intervention
in the SOCS-1 mediated downregulation of PICyts is associated
with the production of overactive immune response, whereas,
interventions either in TLR4 or NFkB-JAK/STAT signalling is
connected with downregulation of overactive immune responses.
Additionally, IFN-b downregulates PICyts in the earlier phase of
signalling, whereas SOCS-1 regulates the levels of cytokines in late
phase. On this account, levels of PICyts fluctuate within different
qualitative levels during sepsis and may provide the basis for the
differences in scientific findings [18,19]. However, these predic-
tions were generated by the use of computer-aided models and
need to be further validated in wet laboratory experiments.
Materials and Methods
The formalism of Rene´ Thomas
Traditionally, biological systems are modelled using ordinary
differential equations, which require time derivatives of expression
levels, temperature, physical state and kinetic rates of entities, etc.
[58]. Due to the complexity of the biological systems, each variable
with all of its parameters are either system specific or rarely
known. For this reason, computer-aided qualitative modelling of
biological systems is generally preferred to understand the
dynamics of the BRN at a preliminary level, which can then be
validated using in vitro experiments.
In 1970, Rene´ Thomas introduced Boolean logic for the
qualitative modelling of BRNs, which was later generalized to
kinetic logic [59–66]. Using kinetic logic, possible dynamics of a
Modelling of TLR4 and JAK/STAT Signalling
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Figure 1. TLR4 and JAK/STAT signalling pathway. Overview of TLR4 and JAK/STAT signalling pathway adopted from previous experimental
studies and databases associated with signalling pathways [20,28–33]. TLR4 activates two separate signalling pathways, including MyD88 and TRIF
dependent pathways [103]. TIRAP/Mal and TRAM are recruited by TLR4 as adaptor proteins to activate MyD88 and TRIF dependent pathways,
respectively [35,103]. Following MYD88 activation, IRAK4 is phosphorylated by MyD88-MAL complex, which ultimately results in the phosphorylation
of IRAK1 protein. Phosphorylated IRAK1 activates TRAF6 [104] which after forming a complex with TAK1-TAB1/2 activates Ikk complex [105]. Ikka and
Ikkb catalyse the phosphorylation of IkB, resulting in its dissociation from NFkB. Afterwards NFkB translocate into nucleus [106] and transcribes
PICyts which results in the subsequent induction of SOCS-1 [48,107]. Along with PICyts, SARM and A20 are also transcribed by NFkB which inhibit
TRIF and TRAF6, respectively [44,108]. Interaction of SOCS-1 with MAL results in its polyubiquitylation and degradation of MAL [42]. SOCS-1 also result
in the degradation of NFkB after binding with its p65 subunit [109]. Moreover, it is also responsible for inhibiting PICyts mediated JAK/STAT signalling
[110]. The alternate pathway for the MyD88 independent induction of NFkB is TRIF which associates with RIP-1 and induce TRAF6 [111]. Cytoplasmic
Modelling of TLR4 and JAK/STAT Signalling
PLOS ONE | www.plosone.org 3 September 2014 | Volume 9 | Issue 9 | e108466
BRN can be determined in a scalable but rigorous manner.
Kinetic logic provided its effectiveness in preference to the
Boolean logic by the successful modelling of different BRNs
[67]. Effectiveness of the kinetic logic has been proved by
analysing lambda phage genetic switch, differentiation process in
helper T cells, control of organ differentiation in Arabidopsis
thaliana flowers and segmentation during embryogenesis in
Drosophila melanogaster [51–53]. The kinetic logic formalism is
an influential method for examining BRNs in which interactions
among entities are well reported. Use of logical parameters
consistent with threshold values eliminate the necessity of various
parameters of expression, temperature, physical state and kinetic
rates etc. Moreover, this approach has the ability to model the
system close to the approximations obtained by differential
equations [55].
Semantics of the Kinetic Logic Formalism
The semantics of the kinetic logic formalism [55] have been
discussed in our previous work [57], where we have explained the
following formal definitions by considering an example of a toy
BRN composed of three entities (shown as Figure 6 in the previous
study). The definitions and the terms necessary to understand the
semantics used in this study have been mentioned below, adapted
from our previous study [57].
Definition 1 (Directed Graph). ‘‘A directed graph is an
ordered pair D(V ,E), where:
N V is the set of all nodes and
N E(V|V is the set of ordered pairs called edges or arcs’’
An edge e.g. (a,b) is directed from an entity or node ‘‘a’’ to ‘‘b’’,
where ‘‘a’’ is the tail and ‘‘b’’ is the head of that respective edge. In
a directed graph, D{(x) and Dz(x) denote the set of predecessors
and successors of a specific node x[V , respectively’’.
domain of TLR4 associates with TRAM and TRIF, and interacts with a complex of TBK1 and Ikki to induce phosphorylation of IRF3 [103]. After
dimerization, phosphorylated IRF3 translocate into nucleus which results in the production of type I IFNs. IFN-b is responsible for the downregulation
of PICyts through a shift of TH1 to TH2 responses and induce immune regulation. Recently SOCS-1 mediated downregulation of IFN-b has been
observed [50].
doi:10.1371/journal.pone.0108466.g001
Figure 2. The BRN of TLR4 and JAK/STAT signalling pathway. The reduced BRN of TLR4 and JAK/STAT signalling pathway is derived from
Figure 1. Nodes represent entities, whereas interactions between them are shown as edges. Sign on the edges represent the type of interaction
between nodes i.e. positive for activation (solid arrows) and negative for inhibition (dotted arrows). Integers ‘‘1’’ and ‘‘2’’ on the edges represent the
threshold levels of entities (see Material and Methods section).
doi:10.1371/journal.pone.0108466.g002
Modelling of TLR4 and JAK/STAT Signalling
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Definition 2 (Biological Regulatory Network). ‘‘A BRN is
a labelled directed graph D(V ,E), where V is a set of nodes which
represents biological entities and E(V|V is a set of all possible
edges, which represent the interaction between entities’’.
N Each edge can be labelled with a pair of variables (s,y), where
s represents the qualitative threshold levels and is a positive
integer and y is ‘‘+’’ or ‘‘–’’ representing the type of
interaction, which can either be ‘‘activation’’ or ‘‘inhibition’’,
respectively.
N Each node e.g. ‘‘a’’ has a limit (la), in its threshold level, which
is equal to its out-degree (the total number of outgoing edges
from ‘‘a’’). This relation can be presented by Vb[Dz(a) and
sab[f1,2,3,::::,rag where raƒla which means that the
threshold levels of entity ‘‘a’’ can be set within a range ‘‘1’’
to ‘‘total number of outgoing edges’’ and because it has only
one outgoing edge towards predecessor ‘‘b’’ so the threshold
level which can be set for it can be only be ‘‘1’’.
N Each entity, e.g. ‘‘a’’, has its abstract expression in the set
Za~f0,1,2,:::,rag.
Definition 3 (States). ‘‘The state of a BRN is a tuple s[M,
where M in terms of entity ‘‘a’’ is:
Figure 3. State graph of TLR4 and JAK/STAT signalling during non-septic and septic conditions. (A) Each node represents a particular
state observed during signalling associated with non-septic and septic conditions. Integers ‘‘0’’, ‘‘1’’ and ‘‘2’’ within the nodes represent qualitative
levels of proteins in the order of TLR4, IFN-b, NFkB, PICyts and SOCS-1. Inactive entities are represented by integer ‘‘0’’ whereas active and overactive
entities are represented by integers ‘‘1’’ and ‘‘2’’, respectively. Nodes and trajectories, which were specifically observed during signalling dynamics
associated with sepsis, are shown in red, whereas common nodes and trajectories found in both conditions are shown in black. Trajectories start from
state ‘‘10000’’, representing the activation of TLR4, and ultimately lead towards ‘‘00000’’, which is a stable state in non-septic condition. On the other
hand, a trajectory labelled with ‘‘g’’ from state ‘‘00000’’ to starting state ‘‘10000’’ results in a cyclic path during signalling dynamics associated with
sepsis. MyD88 and TRIF dependent signalling are shown as black lines and dashed arrows, respectively. Nodes, which represent crosstalk of both
signalling pathways i.e. IFN-b and NFkB with qualitative level ‘‘1’’ are presented in oval shapes. Arrows labelled with Greek small letters are used to
represent trajectories associated with different signalling events (see legend in the figure). The conditions necessary to produce a state graph shown
in the figure are given in Table 1. (B–D) specific states and trajectories which can possibly represent the complete state graph given in (A).
doi:10.1371/journal.pone.0108466.g003
Modelling of TLR4 and JAK/STAT Signalling
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M~Pa[VZa
The qualitative states are represented by vector (Mv)Va[V ,
where v denotes the level of expression of an entity like ‘‘a’’.
According to this definition M is the Cartesian product of the sets
of abstract expressions of all entities. A qualitative state represents
a configuration of all the elements of a BRN at any instant of time.
The number of activators of a particular variable at a given level of
expression are represented by its set of resources (see the definition
of resources given below)’’.
Definition 4 (Resources). ‘‘The set of resources Rva of a
variable a[V at a level v is defined as Rva~fb[D{(a)j
vb§sba and yba~z) or (vbvsba and yba~{)g. The dynamic
behaviours of BRN depends on logical parameters. The set of
these logical parameters is defined as K(D)~fKa(Rva )[ZaVa[Vg.
The parameter Ka(Rva ) (at a level v of a) gives the information
about the evolution of a. There are three cases: 1) if vavKa(Rva )
then va increases by one unit 2) if vawKa(Rva ) then va decreases
Figure 4. State graph of CASE 1-N and 1-S. (A) Each node represents a particular state observed during signalling associated with CASE 1-N and
CASE 1-S. Integers ‘‘0’’, ‘‘1’’ and ‘‘2’’ within the nodes represent qualitative levels of proteins in the order of TLR4, IFN-b, NFkB, PICyts and SOCS-1.
Inactive entities are represented by integer ‘‘0’’ whereas active and overactive entities are represented by integers ‘‘1’’ and ‘‘2’’, respectively. States
and trajectories, which were specifically observed during signalling dynamics associated with CASE 1-S, are shown in red, whereas common states
and trajectories found in both CASES are shown in black. Trajectories start from state ‘‘10000’’, representing the activation of TLR4 and ultimately lead
towards ‘‘00000’’ and ‘‘00121’’, which are stable states in CASE 1-N. On the other hand, only one stable state ‘‘00121’’ was observed during signalling
dynamics associated with CASE 1-S and a trajectory labelled with ‘‘g’’ from state ‘‘00000’’ to starting state ‘‘10000’’ results in cyclic path. Trajectories
associated with loss of SOCS-1 mediated downregulation of PICyts in CASE 1-N and CASE 1-S are presented as bold arrows labelled with symbol ‘‘De’’.
Nodes are labelled with stars in which NFkB and PICyts were active simultaneously and have the probability to lead towards overactive immune
response. MyD88 and TRIF dependent signalling are shown as black lines and dashed arrows, respectively. Nodes, which represent crosstalk of both
signalling pathways i.e. IFN-b and NFkB with qualitative level ‘‘1’’ are presented in oval shapes. Arrows labelled with Greek small letters are used to
represent trajectories associated with different signalling events (see legend in the figure). The conditions necessary to produce a state graph are
shown in the figure are given in Table 3. (B–D) specific states and trajectories which can possibly represent the complete state graph given in (A).
doi:10.1371/journal.pone.0108466.g004
Modelling of TLR4 and JAK/STAT Signalling
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by one unit and 3) if va~Ka(Rva ) then va cannot evolve from its
current level.
It is convenient to describe the evolution from one level to
another by an evolution operator ‘‘ ’’ [68], which is defined in
terms of entity ‘‘a’’ as follows:
va Ka(Rva )~
vaz1 if vavKa(Rva );
va{1 if vawKa(Rva );
va if va~Ka(Rva ):
8><
>:
:
Where va and Ka(Rva )[Z§0’’.
Figure 5. State graph of CASE 2-N and 2-S. (A) Each node represents a particular state observed during signalling associated with CASE 2-N and
CASE 2-S. Integers ‘‘0’’, ‘‘1’’ and ‘‘2’’ within the nodes represent qualitative levels of proteins in the order of TLR4, IFN-b, NFkB, PICyts and SOCS-1.
Inactive entities are represented by integer ‘‘0’’ whereas active and overactive entities are represented by integers ‘‘1’’ and ‘‘2’’, respectively. Nodes
and trajectories, which were specifically observed during signalling dynamics associated with CASE 2-S, are shown in red, whereas common nodes
and trajectories found in both CASES are shown in black. Trajectories start from state ‘‘10000’’, representing the activation of TLR4 and ultimately lead
towards ‘‘00000’’ and ‘‘00121’’, which are stable states in CASE 2-N. On the other hand, only one stable state ‘‘00121’’ was observed during signalling
dynamics associated with CASE 2-S and a trajectory labelled with ‘‘g’’ from state ‘‘00000’’ to starting state ‘‘10000’’ results in cyclic path. Trajectories
associated with loss of SOCS-1 mediated downregulation of PICyts in CASE 2-N and CASE 2-S are presented as bold arrows labelled with symbol ‘‘De’’
whereas loss of SOCS-1 mediated downregulation of IFN-b are labelled with symbol ‘‘Dd’’. MyD88 and TRIF dependent signalling are shown as black
lines and dashed arrows, respectively. Nodes, which represent crosstalk of both signalling pathways i.e. IFN-b and NFkB with qualitative level ‘‘1’’ are
presented in oval shapes. Arrows labelled with Greek small letters are used to represent trajectories associated with different signalling events (see
legend in the figure). The conditions necessary to produce a state graph shown in the figure are given in Table 3. (B–D) specific states and trajectories
which can possibly represent the complete state graph given in (A).
doi:10.1371/journal.pone.0108466.g005
Modelling of TLR4 and JAK/STAT Signalling
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Definition 5 (State Graph). ‘‘Let D be the BRN and va
represents the expression level of an entity e.g. ‘‘a’’ in a state s[M.
Then the state graph of the BRN will be the directed graph
G~(S,T), where S is set of states and T(S|S represents a
relation between states, called the transition relation, such that
s?s’[T if and only if:
N A a unique a[V such that sva=sva ’ and sva ’~sva Ka(Rva ) and
N Vb[V \fagsvb ’~svb ’’
According to this definition states evolve asynchronously, thus,
in a successor state only one entity changes its level.
Reduction of the BRN
One of the limitations of the kinetic logic approach is that it has
been designed to analyse relatively small BRNs because of its
scalability limitations [55]. For example, the TLR4 and JAK/
STAT pathway as given in Figure 1 has 22 entities and on
simulation its state graph would be composed of 6291456 states as
compared to less than 50 states (Figures 3–8) generated by the
reduced BRN (Figure 2).
Figure 6. State graph of CASE 3-N and 3-S. (A) Each node represents a particular state observed during signalling associated with CASE 3-N and
CASE 3-S. Integers ‘‘0’’, ‘‘1’’ and ‘‘2’’ within the nodes represent qualitative levels of proteins in the order of TLR4, IFN-b, NFkB, PICyts and SOCS-1.
Inactive entities are represented by integer ‘‘0’’ whereas active and overactive entities are represented by integers ‘‘1’’ and ‘‘2’’, respectively. Nodes
and trajectories, which were specifically observed during signalling dynamics associated with CASE 3-S, are shown in red, whereas common nodes
and trajectories found in both CASES are shown in black. Trajectories start from state ‘‘10000’’, representing the activation of TLR4, ultimately, lead
towards ‘‘00000’’, which is the stable state in CASE 3-N. On the other hand, a trajectory labelled with ‘‘g’’ from state ‘‘00000’’ to starting state ‘‘10000’’
results in a cyclic path during signalling dynamics associated with CASE 3-S. Trajectories associated with loss of IFN-b mediated downregulation of
PICyts in CASE 3-N and CASE 3-S are presented as bold arrows labelled with symbol ‘‘Dc’’. MyD88 and TRIF dependent signalling are shown as black
lines and dashed arrows, respectively. Nodes, which represent crosstalk of both signalling pathways i.e. IFN-b and NFkB with qualitative level ‘‘1’’ are
presented in oval shapes. Arrows labelled with Greek small letters are used to represent trajectories associated with different signalling events (see
legend in the figure). The conditions necessary to produce a state graph shown in the figure are given in Table 3. (B–D) specific states and trajectories
which can possibly represent the complete state graph given in (A).
doi:10.1371/journal.pone.0108466.g006
Modelling of TLR4 and JAK/STAT Signalling
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The complexity of TLR4 and JAK/STAT pathways was
reduced to make the BRN (shown in Figure 2) and resultant state
graphs (Shown in Figures 3–8) tractable. Starting with the
complete signalling pathways of TLR4 and JAK/STAT, adopted
from previous experimental studies and databases associated with
biological signalling [28–33], the BRN was reduced iteratively by
following the strategies of Naldi et. al. [69] and Assieh et. al. [70].
Briefly, one such example is if an entity X1 activates another entity
X2, which in turn activates X3 such that X3 inhibits X1, then we
can omit X2 and represent this relation as a simple feedback loop
where X1 activates X3 and X3 inhibits X1. In the process of
reduction, the behaviour of the removed entity X2 was preserved
implicitly in the activation of X3 by X1 to account for the related
interactions and their effects on the target nodes. Another example
is given in the Figure 3.3 of the study by Assieh et al. [70], where a
network of 13 proteins (Figure 3.3a) is reduced to 3 proteins
(Figure 3.3b) using the reduction rules. Similarly in the study of
Naldi et.al. [69], Figure 2 is presenting another example of the
BRN reduction.
Figure 7. State graph of CASE 4-N and 4-S. Each node represents a particular state observed during signalling associated with CASE 4-N and
CASE 4-S. Values ‘‘0’’ and ‘‘1’’ within the nodes represent qualitative levels of proteins in the order of TLR4, IFN-b, NFkB, PICyts and SOCS-1. Inactive
entities are represented by integer ‘‘0’’ whereas active entities are represented by integer ‘‘1’’. Trajectories, which were specifically observed during
signalling dynamics associated with CASE 4-S, are shown in red, whereas common states and trajectories found in both CASES are shown in black.
Trajectories start from state ‘‘10000’’, representing the activation of TLR4, ultimately, lead towards ‘‘00000’’, which is a stable state in CASE 4-N. On the
other hand, a trajectory labelled with ‘‘g’’ from state ‘‘00000’’ to starting state ‘‘10000’’ results in a cyclic path during signalling dynamics associated
with CASE 4-S. State ‘‘00121’’ which represents the immune response was absent in state graph and not shown in this figure. MyD88 and TRIF
dependent signalling are shown as black lines and dashed arrows, respectively. Nodes, which represent crosstalk of both signalling pathways i.e. IFN-
b and NFkB with qualitative level ‘‘1’’ are presented in oval shapes. Arrows labelled with Greek small letters are used to represent trajectories
associated with different signalling events (see legend in the figure). The conditions necessary to produce a state graph shown in the figure are given
in Table 3.
doi:10.1371/journal.pone.0108466.g007
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Discrete Modelling of the BRN
GENOTECH (provided at http://code.google.com/p/
genotech/downloads/list. Steps necessary to model a BRN in
GENOTECH have been described in [57]) and GINSIM
(documentation and software for modelling BRNs in GINSIM
are available at www.ginsim.org) [71] facilitated the construction
of qualitative model of BRN (Figure 2) according to Thomas’
formalism. Modelling of the BRN was performed by inserting the
required entities as nodes and drawing the corresponding
interactions as edges. Threshold levels and logical parameters for
each entity were adjusted as discussed below. Using asynchronous
strategy, the results were produced in the form of state graphs
composed of states and trajectories consisting of cycling paths and
paths diverging towards stable states. These state graphs were used
to study the dynamics of the BRN. GENOTECH files and
equivalents in GINSIM format have been provided as Files S1–
S24, for each condition discussed in results.
Threshold values of each entity in the BRN
According to the Definition 2, the threshold level 00s00 is a
positive integer, which represents the minimum qualitative level of
an entity necessary to activate or inhibit its target entities. In
contrast to the Boolean logic, kinetic logic (multivalued) permits
the use of threshold level§1 [61,72]. The threshold values, which
can be used, depend upon the outgoing edges from any entity.
These values range from ‘‘1’’ to the number of outgoing edges
from an entity. The reason for multivalued formalism is that a
particular entity can activate or inhibit its target entities at
different activation levels and thus require more than one
threshold level to perform its role as an activator or inhibitor.
Figure 8. State graph of CASE 5-N and 5-S. (A) Each node represents a particular state observed during signalling associated with CASE 5-N and
CASE 5-S. Integers ‘‘0’’ and ‘‘1’’ within the nodes represent qualitative levels of proteins in the order of TLR4, IFN-b, NFkB, PICyts and SOCS-1. Inactive
entities are represented by integer ‘‘0’’ whereas active entities are represented by integer ‘‘1’’. Nodes and trajectories, which were specifically
observed during signalling dynamics associated with CASE 5-S, are shown in red, whereas common nodes and trajectories found in both CASES are
shown in black. Trajectories start from state ‘‘10000’’, representing the activation of TLR4, ultimately, lead towards ‘‘00000’’, which is a stable state in
CASE 5-N. On the other hand, a trajectory labelled with ‘‘g’’ from state ‘‘00000’’ to starting state ‘‘10000’’ results in a cyclic path during signalling
dynamics associated with CASE 5-S. MyD88 and TRIF dependent signalling are shown as black lines and dashed arrows, respectively. Nodes, which
represent crosstalk of both signalling pathways i.e. IFN-b and NFkB with qualitative level ‘‘1’’ are presented in oval shapes. Arrows labelled with Greek
small letters are used to represent trajectories associated with different signalling events (see legend in the figure). The conditions necessary to
produce a state graph shown in the figure are given in Table 3. (B–D) specific states and trajectories which can possibly represent the complete state
graph given in (A).
doi:10.1371/journal.pone.0108466.g008
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For example SOCS-1 has been implicated for its inhibitory role in
TLR4, NFkB, IFN-b and PICyts mediated signalling [48] but the
specific expression levels of SOCS-1 which are necessary to inhibit
all of these four entities in the presence of other resources
(activators or inhibitors) are not reported. Therefore, according to
Thomas’ formalism, the threshold levels of SOCS-1 for its
interaction with these four entities can be within the range
f1{4g. In order to keep the model simple, the threshold levels of
SOCS-1 were set at level ‘‘1’’. Similarly, for other entities,
including TLR4, IFN-b and NFkB, the threshold levels were set at
‘‘1’’. Only PICyts mediated activation of NFkB-JAK/STAT was
set at ‘‘2’’. Therefore, PICyts was supposed to activate SOCS-1 at
the activation level ‘‘1’’ and NFkB-JAK/STAT at activation level
‘‘2’’. Threshold level ‘‘2’’ was used in speculation that PICyts
Table 1. Logical parameters used for each entity in modelling of non-septic TLR4 and JAK/STAT signalling using the BRN shown in
Figure 2.
S.No. Logical Parameters
1 KTLR4({}) = 0
2 KTLR4({NFkB}) = 0
3 KTLR4({SOCS-1}) = 0
4 KTLR4({SOCS-1, NFkB}) = 0
5 KNFkB-JAK/STAT({}) = 0
6 KNFkB-JAK/STAT({TLR4}) = 1
7 KNFkB-JAK/STAT({IFN-b}) = 1
8 KNFkB-JAK/STAT({PICyts}) = 1
9 KNFkB-JAK/STAT({TLR4, IFN-b}) = 1
10 KNFkB-JAK/STAT({TLR4, PICyts}) = 1
11 KNFkB-JAK/STAT({IFN-b, PICyts}) = 1
12 KNFkB-JAK/STAT({TLR4, PICyts, IFN-b}) = 1
13 KNFkB-JAK/STAT({TLR4, SOCS-1}) = 1
14 KNFkB-JAK/STAT({IFN-b, SOCS-1}) = 1
15 KNFkB-JAK/STAT({PICyts, SOCS-1}) = 1
16 KNFkB-JAK/STAT({TLR4, IFN-b, SOCS-1}) = 1
17 KNFkB-JAK/STAT({TLR4, PICyts, SOCS-1}) = 1
18 KNFkB-JAK/STAT({PICyts, IFN-b, SOCS-1}) = 1
19 KNFkB-JAK/STAT({SOCS-1}) = 0
20 KNFkB-JAK/STAT({SOCS-1, TLR4, IFN-b, PICyts}) = 1
21 KPICyts({}) = 0
22 KPICyts({NFkB}) = 0
23 KPICyts({IFN-b}) = 0
24 KPICyts({SOCS-1}) = 0
25 KPICyts({NFkB, IFN-b}) = 0
26 KPICyts({NFkB, SOCS-1}) = 0
27 KPICyts({IFN-b, SOCS-1}) = 0
28 KPICyts({NFkB, IFN-b, SOCS-1}) = 2
29 KSOCS-1({}) = 0
30 KSOCS-1({PICyts}) = 1
31 KSOCS-1({IFN-b}) = 1
32 KSOCS-1({PICyts, IFN-b}) = 1
33 KIFN-b({}) = 0
34 KIFN-b({TLR4}) = 0
35 KIFN-b({SOCS-1}) = 0
36 KIFN-b({NFkB}) = 0
37 KIFN-b({TLR4, SOCS-1}) = 1
38 KIFN-b({TLR4, NFkB}) = 1
39 KIFN-b({SOCS-1, NFkB}) = 0
40 KIFN-b({TLR4, SOCS-1, NFkB}) = 1
Each logical parameter has been discussed in detail in File S26.
doi:10.1371/journal.pone.0108466.t001
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activate the products of NFkB-JAK/STAT signalling pathway
after reaching a certain qualitative threshold level, which may
differ from its other actions such as activation of SOCS-1 [73–75].
Types of interaction
The entities in a BRN may represent proteins or genes, which
can interact with each other. Depending upon the threshold levels,
entities can either activate or inhibit other entities termed as
evolving or target entities (see Definition 2 where y~z for
activators and y~{ for inhibitors). As shown in the BRN
(Figure 2), TLR4, IFN-b, NFkB and PICyts are the entities, which
can either activate each other or SOCS-1 depending upon their
threshold levels. According to formalism, whenever the activation
of these entities will reach to their threshold levels, generally taken
as ‘‘1’’, then successors of these entities will also be activated. This
relationship can be depicted by sigmoidal graph presented as
Figure 5A in our previous study [57]. It can be seen that an
activator below a threshold level (s) slightly affects the activation
level of its target entity. However, as soon as the activator achieves
its threshold level, then the target entity also reaches to active state
where it can perform its further interactions. In other words,
whenever entity has threshold level ,s then it cannot activate its
target entities but when threshold level of an entity $s then it can
activate its target entities. In this scenario, the entities are termed
as positive regulators or activators when they activate other entities
during the dynamics of the BRN shown as state graphs.
On the other hand, IFN-b, NFkB and SOCS-1 can inhibit
either each other or TLR4 and PICyts. These entities are termed
as negative regulators or inhibitors and process is termed as
downregulation or inactivation. Entities which can inhibit evolving
entities also depend upon their threshold levels. The effect of
inactivation is also of sigmoidal nature and is shown as Figure 5B
in our previous study [57].
Logical parameters of each entity in the BRN
Logical parameters have been described by using the relation
Ktarget entity(fresourcesg)~n where n[f0,1,2,:::g. Where resourc-
es are those entities of BRN, which are connected with evolving or
target entity. These resources can be either activators or inhibitors
depending upon their presence or absence, respectively, during a
particular state. Activators were taken as resources when they were
present in a particular state. On the other hand, inhibitors were
taken as resources only when they were absent during a particular
state.
According to the formalism, the possible number of logical
parameters, which we have to define for each evolving entity
depends upon the number of resources. If the number of resource
is one, then the possible number of logical parameters, which we
have to define, will be two. This relation can be shown as a power
set of the set of regulators (set of activators and inhibitors) of an
entity. Therefore, each logical parameter corresponds to one
element of the power set. In accordance with the Rene´ Thomas’
formalism, the total number of logical parameters for TLR4, IFN-
b, NFkB, PICyts and SOCS-1 are 4, 8, 16, 8 and 4, respectively
(Table 1).
The value n for each logical parameter was unknown a priori,
and was computed using the Selection of Models of Biological
Networks (SMBioNet) tool [76–78]. Briefly, this tool is based on
the kinetic logic formalism of Rene´ Thomas that takes a BRN with
unspecified parameters and Computational Tree Logic (CTL) [79]
formulae of the form W~W1? A=Ef g G=F=Xf gW2 representing a
specific biological behaviour (observation). In the formula W, the
path quantifier A or E governs if a specific property should hold in
all trajectories (A) originating from a current state or in at least one
trajectory (E). Whereas, the state quantifiers G, F and X govern if
a property should hold in all states (G), in a future state (F ), or in
the immediate successor state (X ) in a trajectory (path); and finally
W1 and W2 represent the Boolean logic formulae representing the
initial expression levels and the observed expression levels of the
entities, respectively. In the formula W, the symbol ‘‘?’’ represents
the Boolean implication operator. For example, the formula
W~((TLR4 = 1 AND IFN-b= 0 AND NFkB = 0 AND PICyts = 0
AND SOCS-1 = 0) ? EF(NFkB = 1)) is a CTL formula where
W1~ (TLR4 = 1 AND IFN-b= 0 AND NFkB = 0 AND PI-
Cyts = 0 AND SOCS-1 = 0) representing the initial expression
levels of entities (TLR4 is currently active and others are inactive),
and EF(W2) with W2~(NFkB = 1) represents the observation that
NFkB eventually activates. In this example, AND is the Boolean
conjunction operator. The CTL encoded observed biological
behaviours from the literature pertaining to the TLR4 and JAK/
STAT pathway are given in Table 2. The input and output of the
SMBioNet are provided in File S25.
Value ‘‘0’’ represents that evolving entity deactivates in the
presence of its resources, whereas a value ‘‘1’’ represents activation
of an entity. However, the logical parameter
KPICyts fNFkB, IFN{b, SOCS{1gð Þ was with a value ‘‘2’’
depending upon the threshold level of PICyts for the induction of
JAK-STAT pathway as discussed earlier. The values of these
computed logical parameters were validated by previous literature.
An informal description of the logical parameters with relevant
evidences has been provided as File S26 that form the basis for
using a specific value for each logical parameter given in Table 1.
These logical parameters were further validated by the proved
conjectures [a positive feedback circuit (respectively negative
feedback circuit) is a necessary condition for multistationarity
Table 2. Biological observations and concerned references from previous literature which were used to generate the CTL formula
as given as input to SMBioNet.
S# Biological observations CTL formula in SMBioNet
1 Once TLR4 gets activated, it will then
activate the downstream signaling
in response to infection, which eventually
leads to the induction of NFkB and IFN-b
[103,112–116].
((TLR4 = 1&IFNb= 0&NFkB = 1&PICyts = 0&SOCS1= 0)-.EF(TLR4 = 1&IFNb = 1&NFkB = 1))
2 After a successful immune
response or clearance of infection,
all the entities will be
downregulated [20,25,117].
((TLR4 = 1&IFNb= 0&NFkB = 0&PICyts = 0&SOCS1= 0)-.
EF(AG(TLR4 = 0&IFNb = 0&NFkB = 0&PICyts = 0&SOCS1= 0)))
doi:10.1371/journal.pone.0108466.t002
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(respectively homeostasis). In a BRN a positive feedback circuit
(respectively negative feedback circuit) is the one which contains
even (respectively odd) number of negative interactions] of Rene´
Thomas [55] and biologically observed stable states. Logical
parameters given in Table 1 were finally used to study the
dynamics of the BRN (Figure 2) in the form of state graphs. These
parameters have also been shown as tendency graphs in Figures
S9–S13 using sigmoidal graphs among evolving entities and their
resources.
Modelling of interventions
Models with interventions were derived by removing one or
more of the interactions of IFN-b, SOCS-1, NFkB and PICyts
present in the BRN (Figure 2). Associated logical parameters were
also changed or removed to maintain the integrity of each model
(Table 3). These interventions (discussed as CASES) were used to
observe their impact on the signalling events (effects on the cyclic
paths and stable states during signalling modelled for septic and
non-septic) and for comparison with non-intervened or intact
models. All the models which are discussed in this study have been
provided as files in GENTOCH (Files S1–S12) and GINSIM (Files
S13–S24) formats.
Results
Different perspectives of the TLR4 and JAK/STAT signalling
were studied by simulating septic and non-septic conditions, both
in the presence and absence of specific interactions among entities.
The devised logical parameters for all entities (Table 1) were used
to model non-septic dynamics of TLR4 and JAK/STAT signalling
shown as BRN in Figure 2. Changes in specific logical parameters
by removing respective edges or interactions between the entities
as given in Figure 2 were used to model septic and intervened
signalling (Table 3). State graphs shown in Figures 3–8 represent
signalling events or dynamics of different perspectives of BRN
discussed in detail below. Qualitative levels (0, 1 or 2) of TLR4,
IFN-b, NFkB, PICyts and SOCS-1 represent qualitative states,
which are shown as nodes, whereas trajectories represent possible
progress or evolution paths of entities depending upon the logical
parameters and qualitative threshold levels (Figures 3–8). In each
state graph, state ‘‘10000’’ represents the starting state (activation
of TLR4 as first signal) whereas states of ‘‘00000’’ and ‘‘00121’’
represents the downregulated and overactive immune responses,
respectively.
Signalling in non-septic case
All the logical parameters used in modelling the non-septic
signalling are defined in Table 1 and shown as dummy tendency
graphs in Figures S9–S13. Model related to non-septic condition
has been provided as File S1. Logical parameters devised for each
entity were based on the experimental findings, but the
incorporation of several experimental findings as a single rule for
evolving entity were devised as discussed in the methods. Logical
parameters were devised in such a way that after the production of
overactive immune response (state ‘‘00121’’), the dynamics of the
BRN should reach to a stable state ‘‘00000’’ representing the
downregulation of immune response. Simulation of non-septic
model led to the generation of a state graph shown in Figure 3.
Complete TLR4 mediated induction of TRIF and MyD88
adaptor proteins are represented by the induction of IFN-b
(10000?11000) and NFkB (10000?10100o), respectively. Ac-
cording to the previous experimental studies, MyD88 dependent
pathway is induced in preference to the TRIF dependent pathway
[80,81]. In the state graph, it can be noticed that the induction of
PICyt was achieved only in those trajectories in which NFkB
mediated signalling was activated in preference to IFN-b. On the
other hand, chances for the induction of PICyt were found
comparatively lower in the presence of earlier induced IFN-b.
Probably, this may create a platform for immediately required
immune response against the pathogen. States, which represent a
crosstalk mechanism of MyD88 and TRIF dependent signalling,
are shown within the oval shapes. Downstream to these states, the
presence of SOCS-1 and/or IFN-b compelled the system towards
immunocompromised states (states with level ‘‘0’’ or ‘‘1’’ of
PICyts). Most of the crosstalk states were observed during the
activated TLR4. However, in the absence of TLR4, TRIF
induced activation of NFkB (shown as 01001?01101) can be
specifically observed in trajectories labelled with ‘‘b’’ in Figure 3.
Correlated with previous experimental study, this transition was
produced nearly at the end of dynamics and triggered the late
phase induction of NFkB mediated proinflammatory immune
responses [36].
During dynamics of the BRN, trajectories (labelled with ‘‘a’’ in
Figure 3) were found most important for the over activation of
PICyts which include (10110?10120) and (00110?00120). Both
of these trajectories were associated with the absence of SOCS-1
and IFN-b along with elevated levels of PICyts (shown by level
‘‘2’’). Moreover, both of these trajectories may represent the
importance of TLR4 and JAK/STAT mediated induction of
inflammatory responses.
The presence of IFN-b and/or SOCS-1 at different levels in the
state graph were found necessary to downregulate the levels of
PICyts. After the expression of PICyts, recursive action of IFN-b
and then SOCS-1 maintained the homeostasis of the immune
system by downregulating the levels of PICyts. After achieving the
hyperinflammatory state ‘‘00121’’, dynamics of the BRN were led
towards stable state ‘‘00000’’, which represents the downregula-
tion of the immune system. Trajectories labelled with ‘‘c’’ in
Figure 3 highlights the role of IFN-b mediated downregulation of
PICyts. The presence of IFN-b reduced the chances for induction
of PICyts (trajectories downstream of state ‘‘11100’’) and delayed
effective immune response. However, in the absence of IFN-b, fate
of system was shifted towards NFkB mediated induction of PICyts.
Trajectories labelled with ‘‘d’’ and ‘‘e’’ in Figure 3 represent
SOCS-1 mediated downregulation of IFN-b and PICyts, respec-
tively. Generally, the behaviour of SOCS-1 was found to
downregulate the levels of IFN-b in preference to PICyts.
Indirectly, SOCS-1 allowed PICyts to higher expression levels in
the system and then regulated the same. Some of the trajectories
(labelled with ‘‘f’’ in Figure 3) in the state graph infer the
combination of SOCS-1 and IFN-b mediated downregulation of
PICyts and observed mostly during crosstalk of MyD88 and TRIF
dependent pathways, which led the dynamics towards downreg-
ulated immune response. In this setting, it can be assumed that
SOCS-1 may allow extra time for the induction of PICyts so that
the immune system can cope up with the pathogens. However,
subsequent SOCS-1 mediated inhibition of PICyts may implicate
the decrease in damage to the host by its exacerbating immune
response.
The presence of cyclic paths, termed as strongly connected
components (SCC)-1 and SCC-2, in the state graph can be seen in
Figure S1 and S2, respectively. SCC-1 highlights the importance
of states ‘‘10100’’ and ‘‘10101’’ (Figure S1). The cyclic path
between these two states represent the recurrent activation of
PICyts in non-septic TLR4 signalling with subsequent downreg-
ulation. Due to the presence of IFN-b and SOCS-1, system cycled
through trajectory ‘‘10100?11100?11101?10101’’ and pro-
duced sustained immunosuppression. On the other hand, SCC-2
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Table 3. Intervened signalling.
CASE
Evolving
Entity
Target
entity/ies
Removed
parameters
Changed
parameters
Removed
edge/s in Figure 2.
Produced
Stable states
1-N SOCS-1 PICyts KPICyts({SOCS-1}) = 0,
KPICyts({NFkB, SOCS-1}) = 0,
KPICyts({NFkB, IFN-b, SOCS-1}) = 0
KPICyts({NFkB, IFN-b}) = 2 SOCS-1 mediated
downregulation of PICyts
00000 & 00121
1-S SOCS-1 PICyts KPICyts({SOCS-1}) = 0,
KPICyts({NFkB, SOCS-1}) = 0,
KPICyts({NFkB, IFN-b, SOCS-1}) = 0
KPICyts({NFkB, IFN-b}) = 2,
KTLR4({SOCS-1, NFkB}) = 1
SOCS-1 mediated
downregulation of PICyts
during recurrent TLR4 signalling
00121
2-N SOCS-1 PICyts &
IFN-b
KPICyts({SOCS-1}) = 0,
KPICyts({NFkB, SOCS-1}) = 0,
KPICyts({NFkB, IFN-b,
SOCS-1}) = 0,
KIFN-b({SOCS-1}) = 0,
KIFN-b({TLR4, SOCS-1}) = 1,
KIFN-b({SOCS-1, NFkB}) = 0,
KIFN-b({TLR4, SOCS-1, NFkB}) = 1
KPICyts({NFkB, IFN-b}) = 2 SOCS-1 mediated
downregulation of
IFN-b and PICyts
00000 & 00121
2-S SOCS-1 PICyts &
IFN-b
KPICyts({SOCS-1}) = 0,
KPICyts({NFkB, SOCS-1}) = 0,
KPICyts({NFkB, IFN-b, SOCS-1}) = 0,
KIFN-b({SOCS-1}) = 0,
KIFN-b({TLR4, SOCS-1}) = 1,
KIFN-b({SOCS-1, NFkB}) = 0,
KIFN-b({TLR4, SOCS-1, NFkB}) = 1
KPICyts({NFkB, IFN-b}) = 2,
KTLR4({SOCS-1, NFkB}) = 1
SOCS-1 mediated
downregulation of IFN-b
and PICyts during recurrent
TLR4 signalling
00121
3-N IFN-b PICyts KPICyts({IFN-b}) = 0,
KPICyts({IFN-b, NFkB}) = 0,
KPICyts({IFN-b, SOCS-1}) = 0,
KPICyts({NFkB, IFN-b, SOCS-1}) = 2
KPICyts({NFkB, SOCS-1}) = 2 IFN-b mediated
downregulation of PICyts
00000
3-S IFN-b PICyts &
SOCS-1
KPICyts({IFN-b}) = 0,
KPICyts({IFN-b, NFkB}) = 0,
KPICyts({IFN-b, SOCS-1}) = 0,
KPICyts({NFkB, IFN-b, SOCS-1}) = 2
KPICyts({NFkB, SOCS-1}) = 2,
KTLR4({SOCS-1, NFkB}) = 1
IFN-b mediated
downregulation PICyts during
recurrent TLR4 signalling
00000
4-N NFkB PICyts KPICyts({NFkB}) = 0,
KPICyts({NFkB, IFN-b}) = 0,
KPICyts({NFkB, SOCS-1}) = 0,
KPICyts({NFkB, IFN-b, SOCS-1}) = 2
- NFkB mediated
induction of PICyts
00000
4-S NFkB PICyts KPICyts({NFkB}) = 0,
KPICyts({NFkB, IFN-b}) = 0,
KPICyts({NFkB, SOCS-1}) = 0,
KPICyts({NFkB, IFN-b, SOCS-1}) = 2
KTLR4({SOCS-1, NFkB}) = 1 NFkB mediated induction
of PICyts during recurrent
TLR4 signalling
00000
5-N PICyts NFkB-JAK/STAT KNFkB-JAK/STAT({PICyts}) = 1,
KNFkB-JAK/STAT({TLR4, PICyts}) = 1,
KNFkB-JAK/STAT({IFN-b, PICyts}) = 1,
KNFkB-JAK/STAT({TLR4, PICyts, IFN-b}) = 1,
KNFkB-JAK/STAT({PICyts, SOCS-1}) = 1,
KNFkB-JAK/STAT({TLR4, PICyts,
SOCS-1}) = 1,
KNFkB-JAK/STAT({PICyts, IFN-b,
SOCS-1}) = 1,
KNFkB-JAK/STAT({SOCS-1, TLR4, IFN-b,
PICyts}) = 1
- PICyts mediated induction
of JAK/STAT signalling
00000
5-S PICyts NFkB-JAK/STAT KNFkB-JAK/STAT({PICyts}) = 1,
KNFkB-JAK/STAT({TLR4, PICyts}) = 1,
KNFkB-JAK/STAT({IFN-b, PICyts}) = 1,
KNFkB-JAK/STAT({TLR4, PICyts, IFN-b}) = 1,
KNFkB-JAK/STAT({PICyts, SOCS-1}) = 1,
KNFkB-JAK/STAT({TLR4, PICyts,
SOCS-1}) = 1,
KNFkB-JAK/STAT({PICyts, IFN-b,
SOCS-1}) = 1,
KNFkB-JAK/STAT({SOCS-1,
TLR4, IFN-b, PICyts}) = 1
KTLR4({SOCS-1, NFkB}) = 1 Loss of PICyts mediated
induction of JAK/STAT
signalling during
recurrent TLR4 induction.
00000
Different CASES have been presented with respective changes in parameters. Changes presented here in each CASE accompanied other logical parameters described in
Table 1 to model each CASE.
doi:10.1371/journal.pone.0108466.t003
Modelling of TLR4 and JAK/STAT Signalling
PLOS ONE | www.plosone.org 14 September 2014 | Volume 9 | Issue 9 | e108466
is a representation of the cycle among states produced after the
induction of JAK/STAT pathway (Figure S2). During this cycle,
only SOCS-1 mediated downregulation of PICyts can be seen in
absence of IFN-b.
Signalling in sepsis
The continuous presence of pathogens or recurrent infections can
ignite rigorous immune responses in the host’s body [82]. Previous
experimental studies suggested the role of recurrent induction of
TLRs in persistent infections and sepsis [83,84]. In this study,
continuous induction of TLR4 was the only difference between the
set of logical parameters used for model septic and non-septic
signalling. Therefore, recurrent induction of TLR4, represented by
logical parameter (KTLR4 fSOCS{1, NFkBgð Þ~1), was used
with other logical parameters of entities given in Table 1 to model
the sepsis related signalling. Model related to sepsis has been
provided as File S2. Dynamics of the BRN were studied in the form
of a state graph, which was merged in Figure 3 for the purpose of
comparison. In Figure 3, red highlighted states in squares and
dotted trajectories represent the additional states and trajectories
produced during septic signalling whereas common states and
trajectories both in non-septic and septic systems are shown in black.
Unlike non-septic TLR4 and JAK/STAT signalling, new events
of recurrent TLR4 induction (trajectories 00000?10000, labelled
with ‘‘g’’ and 00010?10010, labelled with ‘‘h’’) and the absence
of stable state ‘‘00000’’ were observed as characteristics of sepsis.
Overall, two phases of signalling were observed in the state graph
shown in Figure 3. The first phase of signalling was comparable to
non-septic signalling whereas the second phase of signalling
represented a late phase of signalling dynamics produced due to
repetitive TLR4 induction. In this phase, TLR4 was re-induced
during pre-existing levels of PICyts (trajectory 00010?10010
labelled with ‘‘h’’). Later to which, influence of IFN-b or SOCS-1
tolerated the levels of PICyts with subsequent degradation of
PICyts. Comparatively, most of the states in the late phase of
dynamics represented immunosuppression due to the presence of
both IFN-b and SOCS-1.
Induction of NFkB as in the trajectory (10010?10110 labelled
with ‘‘k’’ in Figure 3) was the only trajectory, which strengthened
the levels of PICyts and led the system to overactive immune
response (state ‘‘00121’’) in the late phase of signalling. However,
all the trajectories ultimately led the system towards downregu-
lated immune response (state ‘‘00000’’). Subsequent activation of
the new round of TLR4 mediated signalling after the state
‘‘00000’’ represented the recurrent induction of TLR4 (transition
labelled with ‘‘g’’) in absence of any other downstream proteins.
In summary, the phenomenon of oscillation was present repre-
senting activation and inactivation of PICyts during complete
dynamics related to the condition of sepsis along with the
suppressed expression levels of PICyts in late phase of signalling
dynamics of the BRN.
Interventions in signalling
Mutations and/or therapeutic interventions can change the role
of resources with subsequent changes in the dynamics of the BRN
(see Definition 4 in methods section). Interventions were modelled
by removing one or more interactions associated with any entity
present in the BRN (Figure 2) to reproduce mutations or
therapeutic interventions. The effects of interventions in IFN-b,
SOCS-1, NFkB and PICyts mediated signalling were compared
both in septic and non-septic signalling to elaborate their
importance in the dynamics of the BRN. These interventions
are discussed as ‘‘CASES’’ and changes in logical parameters are
mentioned in Table 3. Other possible interventions, given in
Table S1, were also analysed to observe their overall effects on the
system in terms of stable states produced by each type of
intervention.
CASE 1 (Intervention in SOCS-1 mediated downregulation
of PICyts). Intervention in SOCS-1 mediated downregulation of
PICyts during non-septic signalling is discussed as CASE 1-N
whereas in case of sepsis, it is discussed as CASE 1-S. Modelling of
CASE 1-N was performed using the logical parameters given in
Table 1 except with some changes as given in Table 3. The model
is provided as File S3. Figure 4 represents the state graph produced
due to the simulation of CASE 1-N. In this case, two stable states
were observed including downregulated or normal (state ‘‘00000’’)
and overactive PICyt levels (state ‘‘00121’’). The overall dynamics of
the system were found comparable to the non-septic signalling (as
shown in Figure 3) but some trajectories involving SOCS-1
mediated inhibition of PICyts were different (trajectories labelled
with ‘‘De’’ in Figure 4). In those trajectories, SOCS-1 mediated
inhibition of PICyts was suppressed and permitted continuous
activation of PICyts with subsequent induction of JAK/STAT
pathway (stable state ‘‘00121’’). These trajectories were also found
opposite in directions from those observed in non-septic signalling
(trajectories labelled with ‘‘e’’ in Figure 3); where SOCS-1 mediated
downregulation of PICyts led the system towards stable state
‘‘00000’’. IFN-b mediated downregulation of PICyts in CASE 1-N
was found ineffective to reduce the levels of PICyts because IFN-b
performed its inhibitory role in the earlier part of the dynamics
(trajectories labelled with ‘‘c’’ in Figure 4). Moreover, PICyts was
capable enough to induce SOCS-1 mediated inhibition of IFN-b
which results in its continuous inactivated state during later stages of
the signalling. Thus higher levels of PICyts led the system to
overactive immune response (trajectories labelled with ‘‘d’’ in
Figure 4).
It was observed that the system evolved mostly towards stable
state ‘‘00000’’ in absence of activated TLR4. This condition was
true except for those states in which NFkB and PICyts were
present simultaneously in the system (downstream signalling
dynamics after states 10111,00110,00111 and 10120 labelled with
stars in Figure 4). All of these states had a higher probability to
produce overactive immune state (stable state ‘‘00121’’) in the
system. The presence of homeostasis in the state graph was found
comparable to SCC-1 (Figure S1) whereas SOCS-1 mediated
downregulation and homeostasis in PICyts levels was absent.
States and trajectories related to CASE 1-S were incorporated
in Figure 4. Model of CASE 1-S is provided as File S4. Overall,
dynamics of the BRN in CASE 1-S were found similar to the
CASE 1-N but some of the trajectories involving re-activation of
TLR4 were found different (trajectory labelled with ‘‘g’’ in
Figure 4). Instead of two stable states as seen in CASE 1-N, only
one stable state ‘‘00121’’ was found in CASE 1-S. New events of
recurrent TLR4 induction (trajectories 00000?10000, labelled
with ‘‘g’’ and 00010?10010, labelled with ‘‘h’’) were comparable
to signalling in sepsis without any intervention as shown in
Figure 3. Unlike signalling in sepsis without any interventions,
SOCS-1 did not play its part in late phase signalling dynamics.
Induction of IFN-b in the late phase of septic signalling was also
found ineffective to attenuate the overactive immune responses in
the absence of SOCS-1.
CASE 2 (Intervention in SOCS-1 mediated downregulation
of IFN-b and PICyts). One of the important effects on the
dynamics of the BRN would be the complete loss of SOCS-1
mediated inhibition of IFN-b and PICyts so that their levels could
be elevated. To evaluate this, intervention in SOCS-1 mediated
inhibition of IFN-b and PICyts was executed. Intervention in non-
septic state is discussed as CASE 2-N, whereas this intervention in
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case of sepsis is discussed as CASE 2-S. Dynamics of the BRN in
these CASES are shown as a state graph in Figure 5. Modelling was
performed using the logical parameters given in Table 1 along with
certain modifications (Table 3). Moreover, respective edges, which
represent SOCS-1 mediated inhibition of IFN-b and PICyts in
Figure 2, were also removed.
Model of CASE 2-N is provided as File S5. The dynamics of the
BRN produced in CASE 2-N were found comparable to non-
septic case (Figure 3) except those trajectories which reflected
SOCS-1 mediated inhibition of IFN-b and PICyts (trajectories
labelled with ‘‘Dd’’ and ‘‘De’’, respectively in Figure 5). Trajec-
tories labelled with ‘‘Dd’’ and ‘‘De’’ were found opposite in the
direction as compared to their counterparts in non-septic
signalling (Figure 3). Stable states ‘‘00000’’ and ‘‘00121’’ were
comparable to those found in CASE 1-N. Similar to other state
graphs discussed above, the simultaneous presence of NFkB-JAK/
STAT and PICyts led the trajectories mostly towards elevated
levels of PICyts even in the absence of SOCS-1 mediated
inhibition of IFN-b. Homeostatic downregulation was seen
comparable to SCC-1 (Figure S1), whereas another homeostasis
produced during non-intervened signalling (SCC-2) was abolished.
Signalling in CASE 2-S was incorporated into the Figure 5 and
its model is provided as File S6. In this CASE, most of the states
and trajectories associated with sepsis were found comparable to
those in CASE 2-N. Only one stable state ‘‘00121’’ was found in
CASE 2-S, whereas another stable state ‘‘00000’’ led the dynamics
of the BRN towards recurrent induction of TLR4 like other sepsis
related dynamics in this study. New events of recurrent TLR4
induction (trajectories 00000?10000, labelled with ‘‘g’’ and
00010?10010, labelled with ‘‘h’’) were similar to the sepsis related
non-intervened dynamics of the BRN (Figure 3). However, in this
CASE, SOCS-1 could not play its inhibitory role in late phase
signalling dynamics. Moreover, interventions in SOCS-1 mediated
inhibition of IFN-b produced similar results as seen in CASE 1-S
due to the activated levels of TLR4.
CASE 3 (Intervention in IFN-b mediated downregulation
of PICyts). Intervention in IFN-b mediated inhibition of PICyts
during non-septic and septic conditions are discussed as CASE 3-
N and CASE 3-S, respectively. These CASES were used to
evaluate the dynamics of the BRN and consequential immune
responses in the absence of IFN-b mediated inhibition of PICyts.
Intervention was derived by removing the inhibitory edge from
IFN-b to PICyts as given in Figure 2. Modelling was performed
using the logical parameters given in Table 1 with some
exceptions given in Table 3 for CASE 3-N and CASE 3-S.
Models of CASE 3-N and CASE 3-S are also provided as File S7
and File S8, respectively). A state graph of CASE 3-N is shown in
Figure 6.
Only one stable state ‘‘00000’’ was observed during the
dynamics of the BRN associated with CASE 3-N. It was observed
that IFN-b mediated inhibition of PICyts during earlier phase of
signalling was abolished from the system (trajectories labelled with
‘‘Dc’’ in Figure 6). This interaction was speculated to resist the
elevated levels of PICyts as seen above in Figures 3–5. However,
the elevated levels of PICyts were downregulated by SOCS-1
when IFN-b was unable to inhibit PICyts.
Homeostatic signalling in CASE 3-N (SCC-3) was similar to
that produced during the dynamics of non-septic model (SCC-1),
however, trajectories were slightly shifted towards elevated levels of
PICyts (Figure S3). Homeostasis during overactive PICyts (state
‘‘00121’’) was observed in the presence of SOCS-1 (SCC-4 and
SCC-5 shown in Figure S4 and Figure S5, respectively), which
represents that even in the absence of IFN-b, SOCS-1 cater the
inhibition of PICyts.
Signalling in CASE 3-S was integrated in the state graph
produced by CASE 3-N (Figure 6). Most of the trajectories and
nodes were found common except those which involved re-
activation of TLR4, as discussed above. Late phase IFN-b
mediated downregulation of PICyts during septic signalling was
not found.
CASE 4 (intervention in NFkB mediated induction of
PICyts). NFkB mediated induction of PICyts has been targeted
in various experimental studies [85,86]. This targeting was
performed either by degrading the complex of NFkB or by
compromising the resultant gene transcription pathway. The
model was evaluated for this intervention by removing the NFkB
mediated induction of PICyts as given in Figure 2. To model this
intervention, logical parameters given in Table 1 were used with
some exceptions given in Table 3. This intervention in non-septic
and septic signalling are discussed as CASE 4-N and CASE 4-S,
respectively. The models of CASE 4-N and CASE 4-S have been
provided as File S9 and File S10, respectively. Simulation of CASE
4-N resulted in a single normal stable state (00000) with the
absence of PICyts throughout the system (Figure 7). Homeostasis
(SCC-6) was seen only between IFN-b and SOCS-1 (Figure S6).
Dynamics of the BRN produced in CASE 4-N and CASE 4-S
were comparable except the recurrent induction of TLR4, as
discussed above. The results implicate that an immune response
could neglect the elevated endotoxemia and allow the pathogen to
infect within the immunocompromised host due to the complete
absence of PICyts.
CASE 5 (intervention in PICyts mediated induction of
NFkB and JAK/STAT pathway). Intervention in PICyts
mediated induction of NFkB and JAK/STAT pathway during
non-septic signalling is discussed as CASE 5-N whereas in case of
sepsis, it is discussed as CASE 5-S. Modelling of CASE 5-N and
CASE 5-S were performed using the logical parameters given in
Table 1 with exceptions given in Table 3. Moreover, the edge
from PICyts towards NFkB-JAK/STAT, as shown in Figure 2,
was also removed. The models of CASE 5-N and CASE 5-S have
been provided as File S11 and File S12, respectively. The
dynamics of both CASES are shown in Figure 8. Events during
the simulation of CASE 5-N were slightly different from non-septic
signalling (shown in Figure 3), in terms of loss of PICyts mediated
induction of JAK/STAT pathway. Moreover, the higher levels of
PICyts were not observed throughout the state graph, however,
normal levels of PICyts were present. Stable state ‘‘00000’’ was
present in CASE 5-N, however, in CASE 5-S, this state led
towards recurrent induction of TLR4 (trajectories 00000?10000,
labelled with ‘‘g’’). Homeostasis due to the cyclic paths SCC-7 and
SCC-8 in CASE 5-N were found comparable to SCC-1 and SCC-
2 (Figures S7 and Figure S8) except that elevated levels of PICyts
were not observed within any cycle.
Discussion
Methods of high throughput gene expression profiling facilitate
the description of complex cellular regulatory networks and
present pictures of valuable information about the signalling
networks [87,88]. Regardless of the enormous amount of data
associated with molecular and cellular processes produced in
various settings, the dynamicity of biological networks in the
presence of several interconnected factors still need to be further
explored [89]. ‘‘Computational systems biology’’ is a discipline,
which is concerned with modelling of experimentally determined
values to improve our understanding about BRNs [90]. Compu-
tational modelling of BRNs provide useful information about
dynamics of various signalling pathways, including control of
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differentiation process in helper T cells, control of organ
differentiation in Arabidopsis thaliana flowers, segmentation
during embryogenesis in Drosophila melanogaster and TLRs
mediated signalling [51–53].
Sepsis is a complex pathological state of the body, which
involves heterogeneous immune responses of exacerbated inflam-
mation and immunosuppression [82]. Pathophysiology of the
sepsis has been associated with pro- or anti-inflammatory
responses in different scientific studies, which led to the
inconsistency of the overall findings, and failure in its treatment
[4]. Some studies associated the deaths in the early phase of sepsis
with unrestricted and irrational SIRS in the host [91] and impelled
anti-inflammatory treatments [92,93]. On the other hand, it has
also been hypothesized that SIRS is followed by CARS [4,94,95].
Moreover, concomitant production of pro- and anti-inflammatory
responses have also been demonstrated in polymicrobial infectious
challenges, which support the continuous, highly mixed anti-
inflammatory response (MARS) and implicated that both pro- and
anti- inflammatory cytokines are integral parts of sepsis [96,97].
TLR4 is a central mediator of LPS induced TH1 or
proinflammatory responses, whereas induction of inhibitory
mediators can lead the system towards downregulated levels of
PICyts [98]. Moreover, binding of cytokines to JAK/STAT
receptors induce changes in gene expression levels of various other
co-factors necessary for the downregulation of immune response
[30]. In order to study the mechanism of sepsis at cellular level, we
evaluated the qualitative roles of TLR4 and JAK/STAT signalling
with their negative and positive feedback loops necessary to
produce effective immune response.
TLR4 and JAK/STAT mediated signalling was designed in the
current study by incorporating previous experimental studies
associated with interaction of entities and their overall effect in
case of sepsis (Figure 1). Reduction of the model was performed to
reduce the possible states and trajectories produced during
qualitative modelling (Figure 2). In this process, roles of resources
in logical parameters were carefully devised so that useful
information about the role of any entity present in the model
should not be lost. The model was further used with different sets
of logical parameters to produce non-septic, septic and intervened
signalling to produce dynamics in the form of state graphs. The
results of non-septic signalling (Figure 3) were used to compare
any interpretations present in this study.
State graphs produced in non-septic signalling were found
different from signalling during sepsis in terms of recurring
signalling and activation of IFN-b and SOCS-1 in the late phase,
which may reflect the immunosuppressive state of the septic
patient in the later stages of sepsis. In non-septic signalling,
induction of TLR4 and subsequent JAK/STAT signalling mount
a successful immune response, which ultimately culminates in
downregulated immune response. However, during sepsis, absence
of stable state ‘‘00000’’ and recursive signalling through state
‘‘00121’’ can be correlated with the phenomenon of SIRS.
Induction of TLR4 mediated MyD88 and TRIF dependent
signalling produced different responses. MyD88 dependent
signalling was associated with early induction of PICyts whereas
TRIF dependent signalling was associated with late induction of
PICyts through Myd88 independent mechanism. This type of
early PICyts and delayed IFN-b inductions have been suggested in
previous experimental studies associating the time of their onsets in
response to pathogen induced immune reaction [99]. Delayed
activation from previous experimental studies suggested that IFN-
b was produced 24 hours later to Listeria monocytogenes infection
[100]. Moreover, IFN-b has been observed to attenuate the late
hyperinflammatory responses in septic peritonitis [27]. Our study
implicates that induction of IFN-b may be present in two stages of
septic signalling. In the first stage, IFN-b regulates the levels of
PICyts before the induction of SOCS-1, whereas in second stage
IFN-b can be induced and downregulate PICyts in late phases of
sepsis. Chances for the induction of IFN-b and SOCS-1 were
found equal in the late phase of the dynamics of the BRN
associated with sepsis and due to this in late phase dynamics of
sepsis, there are fewer chances for activation of PICyts to higher
levels.
Sequential production and then downregulation of PICyts was
observed as one of the interesting phenomenon. The swing in the
expression levels of PICyts has already been reported which
revealed the pro-inflammation with subsequent immunosuppres-
sion [13]. In our study, proinflammatory state can be correlated
with those states which had higher activation levels of PICyts
(qualitative level ‘‘2’’) whereas immunosuppression can be
correlated with lower levels of PICyts (qualitative level ‘‘0 or 1’’).
SOCS-1 mediated inhibition of PICyts through inactivation of
JAK/STAT signalling was found intriguing in the management of
immunosuppression. While, inactivation of TLR4 and NFkB
mediated induction of PICyts was associated with management of
hyperinflammatory responses. This may suggest that therapeutic
strategies during the course of sepsis should be devised according
to the immune responses and expression levels of SOCS-1 and
IFN-b as discussed in other studies for their role in sepsis
[31,47,82].
In vitro studies suggested that recurrent induction of TLR4
through LPS challenge result in the decreased immune response
known as LPS tolerance [101]. Our study suggests, that late phase
induction of both SOCS-1 and IFN-b may play their roles in LPS
tolerance and can produce immunosuppression. Moreover,
tolerance may be related with complete absence of PICyts levels
even in the continuous signalling through TLR4.
Intervened signalling presented some of the interesting assump-
tions produced during this study. Mutations or therapeutic
intervention of SOCS-1 mediated inhibition of JAK/STAT
signalling may result in the non-reversible hyperinflammatory
process compared to any other intervention studied here.
Moreover, the presence of SOCS-1 can balance the levels of
PICyts even during incapable IFN-b mediated inhibition. On the
other hand, if non-reversible immunosuppression is required, then
intervention of NFkB mediated PICyts expression would produce
competitive results.
The overall dynamics of the BRN have been given in Figure 9-
A to show the pattern of activation and inactivation of entities. It
can be seen that starting from the activation of TLR4, the
dynamics actually proceed greatly towards the activation of IFN-b
and then SOCS-1 during normal signalling. However, in the case
of recurrent signalling, the activation of IFN-b and SOCS-1 at the
same time inhibit the activation of PICyts. Based on these
predictions, we hypothesize that in normal infections, which do
not often lead to sepsis, the phases of regulatory signalling are
somewhat different from those seen in case of sepsis as shown in
Figure 9 (B–C). This is supported by previous experimental studies
in which the continuous presence of pathogens repeatedly induce
immune responses and produce oscillatory levels of PICyts [102].
Recurrent infections, which can lead to sepsis, have the capability
to induce innate immune responses repeatedly. During this state,
PICyts are inhibited to a greater extent which can lead the
immune system of the host towards the temporary immunocom-
promised state. Inhibition may be due to the prior presence of
negative regulatory factors such as SOCS-1 and IFN-b in the
system, which may be induced in some earlier phase of infection or
because of a co-infection. Due to this reason, innate immune
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response may not efficiently generate an effective PICyts burst to
manage the pathogen load. Moreover, the expression pattern of
negative regulators such as SOCS-1 and IFN-b can be detrimental
in case of sepsis. In normal infections, the pattern of IFN-b and
SOCS-1 is sequential, whereas in case of sepsis, this sequential
pattern of IFN-b and SOCS-1 may be changed and system
becomes more vulnerable towards higher levels of pathogen load
due to compromised levels of PICyts.
Conclusion
In summary, logical modelling of TLR4 and JAK/STAT
dependent signalling pathways indicated specifically designed
crosstalk mechanism which can induce a successful pathogenic
response along with management of hyperinflammation. If entities
present in these pathways lose a specific pattern of activation and/
or inactivation, then signalling can lead towards diverse outcomes.
Using computer-aided qualitative approach, we have tried to
highlight these patterns of entities necessary to maintain a balance
in a successful immune response. Qualitative results implicated
that TLR4 and JAK/STAT pathways induced elevated levels of
PICyts with subsequent downregulation. This pattern of activation
and then inactivation of PICyts produced homeostasis in the
system while changes in the inhibitory role of SOCS-1 created
overactive immune responses. The inhibitory role of IFN-b was
observed during the initial stages of dynamics, but it is tempting to
speculate that SOCS-1 possibly inhibit the role of IFN-b during
sepsis but has the ability to manage the hyperinflammatory
condition. Overall, this study suggests that intervention in SOCS-1
mediated PICyts inhibition may produce useful results in case of
immunocompromised septic patients. On the other hand,
intervening the TLR4 or PICyts mediated induction of NFkB-
JAK/STAT pathways may be used for the management of
hyperinflammatory immune responses. This computational study
highlighted many questions with provision of possible answers,
which need further experimental investigations. In the future, we
will perform in vitro experiments to further investigate our
predictions and produce explicit insights into the diagnosis and
treatment of sepsis by involving IFN-b and SOCS-1.
Supporting Information
Figure S1 SCC-1. This cyclic graph represents the homeostatic
regulation of PICyts during physiological signalling dynamics.
(EPS)
Figure S2 SCC-2. This cyclic graph represents the homeostasis
by SOCS-1 mediated downregulation of PICyts during physio-
logical signalling dynamics.
(EPS)
Figure S3 SCC-3. This cyclic graph represents the homeostasis
by IFN-b mediated downregulation of PICyts during CASE 3.
(EPS)
Figure S4 SCC-4. This cyclic graph represents the homeostasis
by SOCS-1 mediated downregulation of PICyts during CASE 3.
(EPS)
Figure S5 SCC-5. This cyclic graph represents the homeostasis
by SOCS-1 mediated downregulation of PICyts during NFkB
downstream signalling in CASE 3.
(EPS)
Figure S6 SCC-6. This cyclic graph represents the homeostasis
between IFN-b and SOCS-1 during CASE 4.
(EPS)
Figure S7 SCC-7. This cyclic graph represents the homeostasis
between IFN-b and SOCS-1 during CASE 5.
(EPS)
Figure S8 SCC-8. This cyclic graph represents the homeostasis
due to SOCS-1 during CASE 5.
(EPS)
Figure S9 Dummy tendency graphs of TLR4 represent-
ing the associated logical parameters used in the
modelling of non-septic condition.
(EPS)
Figure S10 Dummy tendency graphs of IFN-b repre-
senting the associated logical parameters used in the
modelling of non-septic condition.
(EPS)
Figure 9. Implication of the study. (A) Edges labelled with Greek small letters and states as nodes are used to represent trajectories associated
with different signalling events observed in this study (see legend in Figure 3). Specific states and trajectories of normal and recurrent signalling
shown in Figures 3–8 were used to draw the hypothesis shown in (B–C). Possible effects of TLR4 and JAK/STAT signalling on pathogen load,
induction pattern of PICyts, IFN-b and SOCS-1 mediated downregulation of PICyts are shown for non-septic (B) and septic (C) cases. During non-septic
case, the pattern of IFN-b and then SOCS-1 limits the qualitative levels of PICyts along with the successful reduction of pathogen load. On the other
hand, during sepsis, it has been proposed that changed expression pattern of IFN-b and SOCS-1 inhibit the PICyts with resultant increase in the
pathogen load.
doi:10.1371/journal.pone.0108466.g009
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senting the associated logical parameters used in the
modelling of non-septic condition.
(EPS)
Figure S12 Dummy tendency graphs of PICyts repre-
senting the associated logical parameters used in the
modelling of non-septic condition.
(EPS)
Figure S13 Dummy tendency graphs of SOCS-1 repre-
senting the associated logical parameters used in the
modelling of non-septic condition.
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Table S1 Other intervention studies. Other CASES of
intervention in signalling were derived by removing specific
interactions in Figure 2 along with their logical parameters to
observe the possible stable states produced due to each condition.
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